Clinical trial
A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function…
NCT00275262 · Abbott, Industry · Terminated
Key facts
| NCT number | NCT00275262 |
|---|---|
| Title | A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation |
| Official title | Leuprolide Acetate to Enhance Immune Function Post-Autologous Stem Cell Transplantation |
| Lead sponsor | Abbott, Industry |
| Collaborators | Norwood Immunology Limited M.D. Anderson Cancer Center Dana-Farber Cancer Institute |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Mantle Cell Lymphoma |
| Intervention type | Drug |
| Interventions | Leuprolide acetate depot (LAD) 11.25 mg 3 Month, Matched placebo |
| Enrollment | 25 |
| Start date | Feb 1, 2006 |
| Primary completion | Feb 1, 2009 |
| First posted | Jan 11, 2006 |
| Last update posted | May 6, 2010 |
| Countries | United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: